Bottle of Lies: The Inside Story of the Generic Drug Boom Free Audiobook Download by Katherine Eban

A new book tells the story of the rise of "generic" drugs in America. The author explains that while many generic drugs often cost less than their more expensive brand name counterparts, most generic drugs are branded as well and are actually more profitable for drug companies than the brand names.

Katherine Eban, a health and science journalist, dives deep into the history of generic drugs. In her book she relays the story of how an FDA rule change that no longer required drug makers to prove that their product was bioequivalent to the brand name drugs they wanted to challenge allowed companies like Teva Pharmaceuticals and Mylan to produce a wide variety of low-cost medicines such as digoxin, lidocaine patches, and methylphenidate.

"Bottle of Lies" is a powerful look at the way the American pharmaceutical industry has been turned upside down by the introduction of generics. Author Katherine Eban, who worked for years as a correspondent for Forbes and The New York Times, takes readers into the complex world of generic drugs and reveals how this new phenomenon in medical care has changed medicine forever.

Katherine Eban tells her story of the generic drug boom. The book is an account of the dark side of the pharmaceutical industry and how it has affected both consumers, who need drugs to live, and pharmaceutical companies, who have suffered in recent decades as they attempt to stay afloat.

Katherine Eban's book is a chilling story of deception and greed. From the moment generic drugs became legal, pharmaceutical companies began to amass huge profits. This was done in part because they could sell copies of expensive brand-name drugs for fractions of the price, claiming that their drugs were identical to the originals. Eban describes how this phenomenon has been fueled by a "lobby army" of lawyers and lobbyists who have made it their mission to make things as hard as possible for Medicare and other insurance plans.

Drug companies may be to blame for the crisis of counterfeit drugs in the US and around the world. The author argues that it is "inevitable" that generic drugs will someday replace brand-name medications, and she gives a detailed history of how this has been possible. However, as drug prices are so high, there is unlikely to be a true revolution in prescription medicine anytime soon. Nevertheless, there are ways to combat counterfeiting and keep your health safe.